Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series

Therapeutics and Clinical Risk Management · Published 2026-04-01 · DOI 10.2147/tcrm.s586907

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.2147/tcrm.s586907

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles